Louisiana Pharmacies Launch Medical Cannabis Sales

Spread the love

<![CDATA[

Louisiana launched its medical cannabis program last week, and Baton Rouge’s Capitol Wellness Solutions made the first regulated medical cannabis sales in the state to two cancer patients and a veteran suffering from post-traumatic stress disorder (PTSD).

Regulated medical cannabis sales officially launched Aug. 6 in the state’s nine licensed retailers, and Capitol Wellness Solutions made the first sale to Alex Domino, a patient suffering from colon cancer. The pharmacy also dispensed medical cannabis to the first veteran in the state, Gary Hess.

“He has been having to go out of state to get … medical marijuana, and he was so happy that now he can get it in his backyard in Louisiana,” Capitol Wellness Solutions Founder and CEO Randy Mire told Cannabis Dispensary. “He talked a lot about the stigma around it and how he always felt like he was doing something he should not be, and for the first time, now he can wake up and feel like he doesn’t need to look over his shoulder and that he’s doing something illegal in Louisiana.”

Photos courtesy of Capitol Wellness Solutions
One of Capitol Wellness Solutions’ first patients was Gary Hess, a veteran accessing medical cannabis to alleviate PTSD symptoms.

Louisiana approved legislation to distribute medical cannabis in 2016, but the rollout of the program took longer than anticipated due to confusion between the state Department of Agriculture and Forestry and its two medical marijuana license holders, Louisiana State University and Southern University. Under state law, both licensees must work with a private business partner to cultivate and distribute medical cannabis products; LSU contracted with Nevada-based GB Sciences in 2017, and Southern originally partnered with a Louisiana company called Advanced Biomedics before later aligning itself with Pennsylvania-based Ilera Holistic Healthcare, which has since been acquired by TerrAscend Corp.

GB Sciences Louisiana provided the first medical cannabis products sold in the state—30 ml bottles of sublingual tinctures.

Capitol Wellness Solutions became the first pharmacy licensed to sell cannabis products in April 2018. It serves Louisiana’s Capitol Region, one of nine geographical regions in the state where medical cannabis is available.

“There were some challenges, but at the end of the day, it was nice that everyone had patients’ safety in mind,” Mire said. “They wanted to make sure we produced a quality product. So, while it did take longer than we had hoped for, we’re excited that everyone had patients at the forefront and that we’re here now.”

Jeanette Anthony is a Capitol Wellness Solutions patient who is using medical cannabis to treat her cancer.

Patients with qualifying medical conditions must obtain a recommendation for medical cannabis from a certified physician, and cannabis products can only be purchased in one of the state’s nine licensed pharmacies.

“I would say that Louisiana is setting the standard for medical marijuana because it’s really the first to have rules that are in such a formal, professional, medical-geared way [with] a pharmacy and physicians,” Mire said. “I know other states maybe have a pharmacist in the dispensary, but this is the first one where it is operated and governed by a pharmacy board. … It’s really a sense of professionalism around the whole model.”

Mire owns six pharmacies in the state and ships mail order medication to about 35 U.S. states. When advocates began pushing for a medical cannabis program in Louisiana several years ago, Mire joined lobbying efforts to help advance legislation.

“That was six years ago, so to be here today and be able to do the first dispensing of medical marijuana is just something I’m so proud of,” he said.

On the first day of sales, Capitol Wellness Solutions worked with doctors to schedule appointments for each of its patients to avoid an onslaught of traffic. The company works with Metrc, the state-mandated seed-to-sale tracking platform, and regular pharmacy dispensing software systems to manage its inventory.

“We’re used to doing that every day with Schedule II narcotics such as OxyContin, so we’re handling it the same way,” Mire said.

Now that sales are officially under way, Mire and his team are looking forward to a wider variety of cannabis products. “Right now, we’re just utilizing the tincture oils, and GB Sciences is promising in the near future we’re going to get a couple different delivery mechanisms, so we’re excited about that—excited about metered dose inhalers [and] excited about maybe topicals … in the future.”

In the meantime, Mire said patients are providing positive feedback.

“The testimonials that we’ve already gotten from patients are incredible,” he said. “It’s just something to be so proud of to help so many patients. »

error: Content is protected !!
%d blogueurs aiment cette page :